SPONSOR
Gan & Lee Pharmaceuticals.
Total Trials
3
Recruiting
3
Phases
Phase 3, Phase 1
Gan & Lee Pharmaceuticals. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Type 2 Diabetes (T2DM), Diabetes, Obesity/Overweight.
The trial portfolio spans Phase 3, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gan & Lee Pharmaceuticals.
How many clinical trials has Gan & Lee Pharmaceuticals. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Gan & Lee Pharmaceuticals., of which 3 are actively recruiting participants. These trials cover conditions including Type 2 Diabetes (T2DM), Diabetes, Obesity/Overweight. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gan & Lee Pharmaceuticals. research focus on?
Gan & Lee Pharmaceuticals. clinical trials span Type 2 Diabetes (T2DM), Diabetes, Obesity/Overweight. The research pipeline includes Phase 3, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Gan & Lee Pharmaceuticals. clinical trial?
To participate in a Gan & Lee Pharmaceuticals. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gan & Lee Pharmaceuticals. trials with current recruitment status updated daily.
Clinical Trials by Gan & Lee Pharmaceuticals.
NCT07527078 Phase 3
Recruiting
Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
Type 2 Diabetes (T2DM)
NCT07165223 Phase 3
Recruiting
A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
Diabetes
NCT07144098 Phase 1
Recruiting
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function
Obesity/Overweight
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology